CMS should use its Innovation Center to pilot a proposal from the Medicare Payment Advisory Commission (MedPAC) to reform the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), according to a senior fellow at Project HOPE. Gail Wilensky, PhD, writing in The New England Journal of Medicine, said a pilot based on the proposal that MedPAC submitted to Congress would provide “real-world evidence” as to whether or not its idea to eliminate the Merit-Based Incentive Payment System (MIPS) is an improvement.
CMS should use its Center for Medicare & Mediciad Innovation (CMMI) to pilot a proposal from the Medicare Payment Advisory Commission (MedPAC) to reform the Medicare Access and CHIP Reauthorization Act of 2015, or MACRA, according to a senior fellow at Project HOPE.
Gail Wilensky, PhD, writing in The New England Journal of Medicine, said a pilot based on the proposal that MedPAC submitted to Congress would provide “real-world evidence” as to whether or not its idea to eliminate the Merit-Based Incentive Payment System (MIPS) is an improvement.
In January, MedPAC recommended repealing and replacing MIPS, 1 of 2 reimbursement tracks that physicians can enroll in under MACRA. The committee called for MIPS to be replaced with a Voluntary Value Program (VVP), where 2% of clinicians' payment would be withheld if they were not enrolled in an advanced alternative payment model or chose to be evaluated on certain population-based measures.
Wilensky said a pilot would test whether the VVP is better than MIPS in terms of helping clinicians with improving their practice and identifying healthcare organizations that provide good outcomes for beneficiaries.
A pilot could also:
Wilensky wrote that while she agrees with the concerns raised by MedPAC, she likewise has concerns with their proposal to jettison MIPS altogether, citing a lack of support from medical associations, the political realities of a divided Senate and upcoming midterm elections that will make the passage of any legislation difficult, and the fact that no one knows whether the proposal will work as planned or what the unintended consequences might be.
MACRA was passed with bipartisan support.
CMS could work with different stakeholders to “develop a small set of metrics that better reflect outcomes that matter to patients. All payers could then be encouraged to use this reduced set of metrics,” Wilensky wrote.
Reference
Wilensky, GR. Will MACRA improve physician reimbursement? [published online February 28, 2017] N Engl J Med. doi: 10.1056/NEJMp1801673.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
ACA Dependent Coverage Extension and Young Adults’ Substance-Associated ED Visits
September 15th 2025This study examines the impact of the Affordable Care Act (ACA) on substance-associated emergency department (ED) visits among young adults, revealing reduced alcohol-associated visits but unchanged opioid-associated visits.
Read More